• SENSEX 76,617.44
    592.93 (+0.78%)
  • BANKNIFTY 51,348.05
    520.55 (+1.02%)
  • IndusInd Bank
    708.45 1,576.00(%)
  • Kalyan Jewellers
    519.15 794.60(%)
  • Dr Lal Pathlabs
    2,508.00 3,645.00(%)
  • ICICI BLR Growth
    1,003.14 1,001.47(%)
  • Vodafone Idea
    8.33 19.15(%)
  • Bharat Electron
    274.50 204.00(%)
  • Quadrant Future
    605.00 743.45(%)
  • Zomato Ltd
    212.60 304.50(%)
  • SRF
    2,986.25 3,074.95(%)
  • Bengal & Assam
    7,450.00 11,498.90(%)
  • ICICI Bank
    1,338.00 1,372.50(%)
  • Mazagon Dock
    2,610.00 2,929.98(%)
  • Suzlon Energy
    57.74 86.04(%)
  • SpiceJet
    46.10 79.90(%)
  • Dixon Technolog.
    13,485.00 19,149.80(%)
  • Adani Green
    944.95 2,173.65(%)
  • Aegis Logistics
    830.35 1,035.70(%)
  • Hind.Aeronautics
    4,252.00 5,675.00(%)
  • M & M
    2,660.50 3,276.30(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Biocon Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 14801.0
  • ISIN : INE376G01013
342.05 3 (0.87%)
  • As on 03 Apr 2025 (EOD)

  • Today’s Low

    334.85

  • Today’s High

    344.50

  • Open

    337.85

  • Perv Close

    339.10

  • 52W Low

    259.85

  • 52W High

    404.70

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    41,066.52

  • Div & Yield %

    0.15

  • Book Value(₹)

    90.70

  • Debt-Equity Ratio

    0.87

  • AGM Date

    02-Apr-2025

  • EPS

    0.12

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.91

  • Mar.Cap (₹Cr.)

    41,066.52

  • RONW (%)

    6.89

  • ROCE (%)

    6.35

Score Board

  • Equity (₹ in Cr.)

    600.30

  • BV (₹)

    90.70

  • Sales( ₹ in Cr.)

    2,127.30

  • NP (in Cr.)

    105.89

  • NP Var(%)

    894.0

  • Div%

    10.0

  • CPS (₹)

    1.90

  • EPS (₹)

    0.90

  • Traded Value (₹ in Lakhs)

    41,090.54

  • 52 Week High

    404.70

  • 52 Week Low

    259.85

  • Price BSE

    342.0

  • Price NSE

    342.00

  • Market Capital( in Cr.)

    41,090.54

  • P/C Ratio

    180.90

  • P/E Ratio

    387.80

  • Price Vs.BV

    0.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 2,127.30 1,992.90 1,738.20 2,028.40 1,988.40 1,785.70
Excise Duty 1,712.40 1,729.40 1,494.90 1,818.80 1,811.70 1,683.20
Net Sales 2,127.30 1,992.90 1,738.20 2,028.40 1,988.40 1,785.70
Other Income 193.00 271.40 187.20 150.20 201.70 108.90
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 2,320.30 2,264.30 1,925.40 2,178.60 2,190.10 1,894.60
EXPENDITURE :
Raw Materials 1,712.40 1,729.40 1,494.90 1,818.80 1,811.70 1,683.20
Power & Fuel Cost 1,712.40 1,729.40 1,494.90 1,818.80 1,811.70 1,683.20
Employee Cost 452.30 433.80 367.70 390.20 344.80 289.10
Other Manufacturing Expenses -28.10 32.90 33.00 66.00 9.90 18.70
Selling & Administrative Expenses 135.00 112.20 106.70 128.40 208.40 222.40
Miscellaneous Expenses -28.10 32.90 33.00 66.00 9.90 18.70
Less : Pre-operative Expenses Capitalised :
Total Expenditure 2,184.50 2,155.90 1,785.70 1,819.80 1,801.60 1,670.30
Operating Profit 370.70 406.30 361.50 333.00 311.60 256.70
Interest 198.80 69.60 0.40 0.40 1.20 2.60
Gross Profit 150.30 2,971.20 139.70 358.80 548.20 423.00
Depreciation 121.10 116.90 108.20 103.50 98.00 92.30
Profit Before Tax 150.30 2,971.20 139.70 358.80 548.20 423.00
Tax 15.10 25.60 32.20 46.20 85.70 123.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 15.90 -9.90 -7.10 4.80 7.50 -9.90
Reported Net Profit 119.30 2,848.40 86.10 280.50 436.30 378.30
Extraordinary Items 150.30 2,971.20 139.70 358.80 548.20 423.00
Adjusted Net Profit 119.30 2,848.40 86.10 280.50 436.30 378.30
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 11.70 129.10
Statutory Appropriations 60.03 180.09 60.03 0.00 0.00 60.00
P & L Balance carried down 119.30 2,848.40 86.10 280.50 436.30 378.30
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 10.00 30.00 10.00 0.00 0.00 20.00
Dividend Per Share(Rs) 0.50 1.50 0.50 0.00 0.00 1.00
Earnings Per Share-Unit Curr 1.00 23.87 0.72 2.36 3.72 4.16
Book Value 60.03 180.09 60.03 0.00 0.00 60.00
Book Value(Adj)-Unit Curr 60.03 180.09 60.03 0.00 0.00 60.00

Shareholding Pattern

  • Promoter Group

    60.64%

  • Public Share Holding

    39.14%

  • Custodian

    0.22%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 237,211,164 19.76 237,211,164 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 6,231,042 6,231,042.00 6,231,042 6,231,042
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 243,442,206 20.28 243,442,206 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 484,581,970 40.36 484,581,970 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 484,581,970 40.36 484,581,970 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 29,240 0.00 29,240 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 67,925,927 5.66 67,925,927 239
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 77,164,613 6.43 77,164,613 14
Mutual Funds / UTI 103,060,261 8.58 103,060,261 29
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 4,222,225 0.35 4,222,225 11
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 252,402,266 21.02 252,402,266 297
2] Non Institution
Bodies Corporate 16,590,861 1.38 16,590,861 1,684
Clearing Members 10,308 0.00 10,308 15
Directors of their Relatives 7,320,441 0.61 7,320,441 3
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 12,737,741 1.06 12,179,533 8,559
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 5,192,859 0.43 5,192,679 6,903
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 68,672,590 5.72 68,577,610 268
Individuals holding nominal share capital up to Rs. 1 lakh 100,220,600 8.35 100,208,918 409,956
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 954,782 0.08 954,782 11
Others 5,796,917 0.48 5,796,917 4
Sub Total 217,497,099 18.12 216,832,049 427,403
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 2,676,459 0.22 2,676,459 1
Total Shares held by Custodians and against which Depository Receipts have been issued 2,676,459 0.22 2,676,459 1
Grand Total ( A + B + C ) 1,200,600,000 100.00 1,199,934,950 427,705

Company Background

Biocon LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Biocon Ltd
  • BSE Code : 14801.0
  • ISIN : INE376G01013

  • Incorporation Year

    1978

  • Registered Office

    20th KM Hosur Road Hebbagodi
    Electronic City P O, Bangalore,
    Karnataka-560100

  • Telephone

    91-80-28082808

  • FAX

    91-80-28523423

  • Chairman

    Kiran Mazumdar Shaw

  • Managing Director

    SIDDHARTH MITTAL

  • Company Secretary

    Mayank Verma

  • Auditor

    BSR & Co LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Biocon Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Biocon 342.25 2,320.30 2,127.30 68.31 2.61
Abbott India 29,572.60 6,097.18 5,848.91 47.09 44.71
Astrazeneca Phar 8,100.10 1,330.33 1,295.53 208.82 33.26
P & G Health Ltd 5,259.35 1,166.89 1,151.26 36.90 39.76
Glaxosmi. Pharma 2,776.60 3,530.73 3,407.25 55.21 44.44
Cipla 1,452.70 17,645.00 16,574.34 24.90 20.10
Amrutanjan Healt 645.10 437.58 421.23 37.81 20.84
Fermenta Biotec. 292.05 315.24 307.09 27.68 4.10
Guj. Themis Bio. 272.20 174.19 169.82 56.36 44.82
Bliss GVS Pharma 120.00 638.96 605.46 27.46 11.19
Ambalal Sarabhai 37.31 11.70 3.81 15.94 1.92